##gff-version 3
##sequence-region O15205 1 165
O15205	UniProtKB	Chain	1	165	.	.	.	ID=PRO_0000114893;Note=Ubiquitin D	
O15205	UniProtKB	Domain	6	81	.	.	.	Note=Ubiquitin-like 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00214	
O15205	UniProtKB	Domain	90	163	.	.	.	Note=Ubiquitin-like 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00214	
O15205	UniProtKB	Site	164	165	.	.	.	Note=Activation by thioester intermediate formation with UBA6	
O15205	UniProtKB	Natural variant	51	51	.	.	.	ID=VAR_024273;Note=L->S;Dbxref=dbSNP:rs2076484	
O15205	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_024274;Note=I->T;Dbxref=dbSNP:rs2076485	
O15205	UniProtKB	Natural variant	95	95	.	.	.	ID=VAR_024275;Note=S->P;Dbxref=dbSNP:rs2076486	
O15205	UniProtKB	Natural variant	99	99	.	.	.	ID=VAR_025401;Note=A->G;Dbxref=dbSNP:rs2076487	
O15205	UniProtKB	Natural variant	120	120	.	.	.	ID=VAR_052693;Note=E->K;Dbxref=dbSNP:rs17184290	
O15205	UniProtKB	Natural variant	160	160	.	.	.	ID=VAR_025402;Note=C->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10200259,ECO:0000269|PubMed:14574404,ECO:0000269|PubMed:9368598,ECO:0000269|Ref.4;Dbxref=dbSNP:rs8337,PMID:10200259,PMID:14574404,PMID:9368598	
O15205	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_024276;Note=C->F;Dbxref=dbSNP:rs7757931	
O15205	UniProtKB	Mutagenesis	11	11	.	.	.	Note=Decreases interaction with MAD2L1%2C no effect on the interaction with HDAC6%2C UBA6%2C NUB1 and SQSTM1 and moderately attenuates UBD-induced tumor formation in vivo%3B when associated with Q-13. Complete loss of interaction with MAD2L1%2C no effect on the interaction with TP53/p53%2C HDAC6%2C UBA6%2C NUB1 and SQSTM1 and significantly attenuates UBD-induced tumor formation in vivo%3B when associated with Q-13%3B D-75%3B D-77 and Q-79. H->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25422469;Dbxref=PMID:25422469	
O15205	UniProtKB	Mutagenesis	13	13	.	.	.	Note=Decreases interaction with MAD2L1%2C no effect on the interaction with HDAC6%2C UBA6%2C NUB1 and SQSTM1 and moderately attenuates UBD-induced tumor formation in vivo%3B when associated with D-11. Complete loss of interaction with MAD2L1%2C no effect on the interaction with TP53/p53%2C HDAC6%2C UBA6%2C NUB1 and SQSTM1 and significantly attenuates UBD-induced tumor formation in vivo%3B when associated with D-11%3B D-75%3B D-77 and Q-79. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25422469;Dbxref=PMID:25422469	
O15205	UniProtKB	Mutagenesis	75	75	.	.	.	Note=Decreases interaction with MAD2L1%2C no effect on the interaction with HDAC6%2C UBA6%2C NUB1 and SQSTM1 and moderately attenuates UBD-induced tumor formation in vivo%3B when associated with D-77 and Q-79. Complete loss of interaction with MAD2L1%2C no effect on the interaction with TP53/p53%2C HDAC6%2C UBA6%2C NUB1 and SQSTM1 and significantly attenuates UBD-induced tumor formation in vivo%3B when associated with D-11%3B Q-13%3B D-77 and Q-79. H->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25422469;Dbxref=PMID:25422469	
O15205	UniProtKB	Mutagenesis	77	77	.	.	.	Note=Decreases interaction with MAD2L1%2C no effect on the interaction with HDAC6%2C UBA6%2C NUB1 and SQSTM1 and moderately attenuates UBD-induced tumor formation in vivo%3B when associated with D-75 and Q-79. Complete loss of interaction with MAD2L1%2C no effect on the interaction with TP53/p53%2C HDAC6%2C UBA6%2C NUB1 and SQSTM1 and significantly attenuates UBD-induced tumor formation in vivo%3B when associated with D-11%3B Q-13%3B D-75 and Q-79. T->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25422469;Dbxref=PMID:25422469	
O15205	UniProtKB	Mutagenesis	79	79	.	.	.	Note=Decreases interaction with MAD2L1%2C no effect on the interaction with HDAC6%2C UBA6%2C NUB1 and SQSTM1 and moderately attenuates UBD-induced tumor formation in vivo%3B when associated with D-75 and D-77. Complete loss of interaction with MAD2L1%2C no effect on the interaction with TP53/p53%2C HDAC6%2C UBA6%2C NUB1 and SQSTM1 and significantly attenuates UBD-induced tumor formation in vivo%3B when associated with D-11%3B Q-13%3B D-75 and D-77. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25422469;Dbxref=PMID:25422469	
O15205	UniProtKB	Mutagenesis	164	165	.	.	.	Note=Impaired thioester formation-mediated activation by UBA6. Loss of interaction with UBA6 and SQSTM1. No effect on its interaction with MAD2L1%2C HDAC6 and NUB1. GG->AA;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17889673,ECO:0000269|PubMed:25422469;Dbxref=PMID:17889673,PMID:25422469	
O15205	UniProtKB	Beta strand	10	17	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GF1	
O15205	UniProtKB	Beta strand	20	24	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GF1	
O15205	UniProtKB	Helix	30	41	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GF1	
O15205	UniProtKB	Helix	45	47	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GF1	
O15205	UniProtKB	Beta strand	48	52	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GF1	
O15205	UniProtKB	Beta strand	61	63	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GF1	
O15205	UniProtKB	Helix	64	66	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GF1	
O15205	UniProtKB	Beta strand	72	80	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GF1	
O15205	UniProtKB	Beta strand	90	96	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GF2	
O15205	UniProtKB	Beta strand	101	103	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GF2	
O15205	UniProtKB	Helix	112	122	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GF2	
O15205	UniProtKB	Helix	127	129	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GF2	
O15205	UniProtKB	Beta strand	130	133	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GF2	
O15205	UniProtKB	Helix	145	148	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GF2	
O15205	UniProtKB	Beta strand	154	160	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GF2	
